Correlation Between Cadrenal Therapeutics, and Cingulate
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Cingulate, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Cingulate.
Diversification Opportunities for Cadrenal Therapeutics, and Cingulate
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cadrenal and Cingulate is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Cingulate go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Cingulate
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 2.54 times more return on investment than Cingulate. However, Cadrenal Therapeutics, is 2.54 times more volatile than Cingulate. It trades about 0.04 of its potential returns per unit of risk. Cingulate is currently generating about 0.01 per unit of risk. If you would invest 0.15 in Cadrenal Therapeutics, Common on August 27, 2024 and sell it today you would earn a total of 1,499 from holding Cadrenal Therapeutics, Common or generate 999233.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 94.15% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Cingulate
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Cingulate |
Cadrenal Therapeutics, and Cingulate Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Cingulate
The main advantage of trading using opposite Cadrenal Therapeutics, and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. HCW Biologics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals |
| Cingulate vs. Eliem Therapeutics | Cingulate vs. HCW Biologics | Cingulate vs. Scpharmaceuticals | Cingulate vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |